Product Images Tadalafil

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Tadalafil NDC 51655-487 by Northwind Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 51655 487 52

Label - 51655 487 52

NDC 51655-487-52 Rova 1120 is a pack of 30 tablets of Tadalafil, USP each containing 5mg of the drug. These tablets are meant for prescription-only use and should be stored at a temperature range of 15°C-30°C (59°F-86°F). The tablets should not be broken before consumption, and the entire dose must be taken. The lot number is 0000000000 which has been repackaged by Northwind Phamaceuticals from the manufacturer Accord Healthcare's product identified by GTIN 0035165487525 and S/N 000000000000000 with the expiry date and lot number both marked as 00/00/0000 and 0000000000 respectively. The package has to be kept in the original container out of children's reach.*

Figure - tadalafil figure1

Figure - tadalafil figure1

This is a chart showing the difference in blood pressure (mmHg) between Tadalafil and Placebo for both standing and supine positions. There is no further context or explanation provided.*

Figure - tadalafil figure2

Figure - tadalafil figure2

The text appears to represent a chart or table with measurements related to the use of Tadalafil and doxazosin medication. The first column may be time in hours after medication intake, and the second column may represent some form of measurement. The other characters and symbols seem to be irrelevant or unreadable, and therefore the nature or purpose of the measurements is not available.*

Figure - tadalafil figure3

Figure - tadalafil figure3

The text describes a table showing Systolic Blood Pressure (in mmHg) for different treatments (20 mg tadalafil or placebo) and different times after administration (-e- represents no data). The treatments are combined with 8 mg doxazosin and are administered at 8:00. One treatment is also administered at 20:00. Therefore, the table shows the effect of the treatments on blood pressure at different times. No information about the study, context or results is given.*

Figure - tadalafil figure4

Figure - tadalafil figure4

This is a graph displaying the plasma concentration of Tadalafil in micrograms per liter (ug/L) over time in hours. The graph shows the concentration after a single 20-mg dose of Tadalafil, a single 5-mg dose, and a once-daily 5-mg dose for 5 consecutive days. The concentrations range from 500 ug/L down to 100 ug/L. The graph spans a time range of 120 hours.*

Figure 5 - tadalafil figure5

Figure 5 - tadalafil figure5

The text describes the change in the IPSS (International Prostate Symptom Score) total score during a treatment with tadalafil compared to a placebo, over a duration of 12 weeks. The graph shows that tadalafil at a certain dosage resulted in a significant improvement in symptoms compared to the placebo, with a p-value <0.01.*

Figure 6 - tadalafil figure6

Figure 6 - tadalafil figure6

Figure 7 - tadalafil figure7

Figure 7 - tadalafil figure7

Figure 8 - tadalafil figure8

Figure 8 - tadalafil figure8

Chemical Structure - tadalafil structure

Chemical Structure - tadalafil structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.